Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
NCT03802838 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2019-01-14
Summary
To explore the effects of combined traditional Chinese and Western medicine( Chinese acupuncture combined with Amisulpride Tablets) on negative symptoms, cognitive function and social function in patients with schizophrenia, and the side effects and safety of Chinese acupuncture combined with Amisulpride Tablets.
Conditions
Interventions
- DEVICE
-
acupuncture
Schizophrenia with negative symptoms were treated with Amisulpride, and the patients still remained negative symptoms and cognitive impairment.Amisulpride is allowed in a dose range of 50-1200 mg / d, once or twice a day for at least 12 weeks. These patients were combined with acupuncture. Acupuncture points include:'Yintang', 'Shenting', 'Taiyang', 'Jingming', 'Zanzhu', 'Yuyao', 'Jiaosun', 'Baihui', 'Fengchi', 'Anmian'.
- DRUG
-
Amisulpride
Schizophrenia with negative symptoms were treated with Amisulpride, and the patients still remained negative symptoms and cognitive impairment.Amisulpride is allowed in a dose range of 50-1200 mg / d, once or twice a day for at least 12 weeks.
Sponsors & Collaborators
-
Shanghai Mental Health Center
lead OTHER
Principal Investigators
-
Zhenghui YI · SHANGHAI MENTAL HEALTH CENTRE
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2019-04-01
- Completion
- 2019-09-30
Countries
- China
Study Locations
More Related Trials
-
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
NCT03652974 ·Status: COMPLETED ·Phase: PHASE4
-
Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
NCT05159349 ·Status: RECRUITING
-
Shiatsu Adjuvant Therapy And Placebo For Schizophrenia
NCT00788970 ·Status: UNKNOWN ·Phase: NA
-
Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia
NCT04859504 ·Status: COMPLETED ·Phase: NA
-
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
NCT05542212 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
NCT01263080 ·Status: COMPLETED ·Phase: PHASE4
-
Mindfulness Psychoeducation Program for Schizophrenia
NCT03632278 ·Status: UNKNOWN ·Phase: NA
-
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia
NCT05310955 ·Status: UNKNOWN ·Phase: NA
-
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483 ·Status: UNKNOWN ·Phase: NA
-
Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients
NCT04553835 ·Status: UNKNOWN ·Phase: NA
-
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
NCT05192304 ·Status: UNKNOWN ·Phase: PHASE1
-
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445 ·Status: UNKNOWN ·Phase: NA
-
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients
NCT04511663 ·Status: COMPLETED ·Phase: NA
-
Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
NCT03329287 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.
NCT06356389 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia
NCT02040883 ·Status: UNKNOWN ·Phase: PHASE4
-
Peer-led Psycho-education for Schizophrenia
NCT03246932 ·Status: COMPLETED ·Phase: NA
-
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573 ·Status: RECRUITING ·Phase: PHASE3
-
Financial Incentives to Improve Acceptance of Antipsychotic Injections
NCT03192631 ·Status: UNKNOWN ·Phase: NA
-
Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
NCT01391390 ·Status: COMPLETED ·Phase: NA
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
NCT01688037 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia
NCT05919823 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Speech Competition Training on Auditory Hallucination in Schizophrenia
NCT05850923 ·Status: UNKNOWN ·Phase: NA
-
Effects of RAS in SZ
NCT07086040 ·Status: NOT_YET_RECRUITING ·Phase: NA